Delivery Order SPE2DB24D2216-SPE2DB26FGMAM
- Not listed
- The Defense Logistics Agency awarded a $14,087.43 delivery order to AmerisourceBergen Drug Corp for Ozempic 2 mg/dose (8 mg/3 ml) 3 ml vials on September 22, 2025, with completion scheduled for September 23, 2025. This non-set-aside, firm fixed-price delivery order represents a routine pharmaceutical procurement under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle active through December...
- The Defense Logistics Agency awarded a delivery order valued at $12,272.82 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL quantities. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of June 26, 2025, issued on June 25, 2025. The contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running...
- The Defense Logistics Agency awarded a delivery order valued at $4,770.06 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. This competitively awarded, firm fixed-price delivery order was issued on August 6, 2025, with an ultimate completion date of August 7, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The order represents a single delivery under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $53,875.27 delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3ml vials, with an ultimate completion date of August 20, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $25,062.96 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by November 18, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $30,288.15 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml vials, with an ultimate completion date of July 24, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $27,497.95 delivery order to AmerisourceBergen Drug Corp for Ozempic 1 mg/dose (4 mg/3 mL) 3 mL vials, with an ultimate completion date of September 2, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $11,831.08 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. The contract, issued on October 28, 2025, with an ultimate completion date of October 29, 2025, utilizes firm fixed price pricing and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $23,564.75 delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials, with an ultimate completion date of October 28, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $46,093.38 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml vials. The contract, which was competitively awarded with no set-aside designation, has an ultimate completion date of September 17, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- SPE2DB24D2216Indefinite Delivery Contract
- SPE2DB24D2216-SPE2DB26FGMAMDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,911.20 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 ml) in 3 ml vials. This is a firm fixed price, non-set-aside contract with an ultimate completion date of October 31, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply vehicle running through December 2026 that supports military healthcare systems globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal medical procurement vendor for the Department of Defense and related healthcare systems. The company maintains an extensive portfolio of competitively awarded contracts with DLA covering a wide range of pharmaceutical products, medical supplies, vaccines, and specialty medications across multiple therapeutic domains. This particular delivery order for Ozempic, a diabetes medication, exemplifies the company's role in supplying brand-name pharmaceuticals necessary to support military medical readiness and veteran healthcare requirements through its established prime vendor relationship with DLA.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.9k | 10/30/25 |